Name | Number of supported studies | Average coverage | |
---|---|---|---|
mast cell | 20 studies | 31% ± 17% | |
CD4-positive, alpha-beta T cell | 17 studies | 27% ± 10% | |
naive thymus-derived CD4-positive, alpha-beta T cell | 14 studies | 24% ± 6% | |
naive thymus-derived CD8-positive, alpha-beta T cell | 9 studies | 23% ± 5% | |
CD4-positive, alpha-beta memory T cell | 8 studies | 21% ± 6% | |
T cell | 8 studies | 22% ± 5% | |
regulatory T cell | 6 studies | 21% ± 6% | |
hematopoietic stem cell | 5 studies | 27% ± 8% | |
T follicular helper cell | 5 studies | 23% ± 4% | |
glutamatergic neuron | 5 studies | 49% ± 14% | |
megakaryocyte-erythroid progenitor cell | 4 studies | 51% ± 15% | |
hematopoietic precursor cell | 3 studies | 28% ± 3% | |
effector memory CD4-positive, alpha-beta T cell | 3 studies | 28% ± 3% | |
CD8-positive, alpha-beta T cell | 3 studies | 27% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 34% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 97% | 358.92 | 562 / 578 | 72% | 2.21 | 828 / 1155 |
prostate | 72% | 166.82 | 177 / 245 | 47% | 1.01 | 234 / 502 |
uterus | 72% | 149.11 | 122 / 170 | 44% | 1.03 | 202 / 459 |
bladder | 71% | 174.48 | 15 / 21 | 39% | 1.00 | 195 / 504 |
ovary | 91% | 378.47 | 164 / 180 | 18% | 0.31 | 79 / 430 |
stomach | 51% | 89.01 | 184 / 359 | 49% | 1.31 | 141 / 286 |
lymph node | 0% | 0 | 0 / 0 | 100% | 24.38 | 29 / 29 |
spleen | 100% | 900.14 | 241 / 241 | 0% | 0 | 0 / 0 |
breast | 33% | 49.36 | 152 / 459 | 66% | 2.42 | 737 / 1118 |
peripheral blood | 99% | 1596.58 | 919 / 929 | 0% | 0 | 0 / 0 |
intestine | 61% | 319.43 | 593 / 966 | 37% | 0.99 | 194 / 527 |
kidney | 24% | 68.97 | 21 / 89 | 71% | 2.92 | 644 / 901 |
esophagus | 55% | 119.93 | 797 / 1445 | 40% | 0.92 | 73 / 183 |
brain | 49% | 3302.84 | 1296 / 2642 | 43% | 7.60 | 302 / 705 |
thymus | 41% | 112.13 | 266 / 653 | 50% | 8.86 | 300 / 605 |
skin | 30% | 52.27 | 548 / 1809 | 51% | 2.75 | 241 / 472 |
tonsil | 0% | 0 | 0 / 0 | 80% | 3.34 | 36 / 45 |
pancreas | 2% | 1.80 | 5 / 328 | 65% | 2.39 | 115 / 178 |
adipose | 60% | 117.85 | 728 / 1204 | 0% | 0 | 0 / 0 |
liver | 5% | 5.86 | 11 / 226 | 19% | 0.58 | 77 / 406 |
blood vessel | 13% | 28.69 | 175 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0.43 | 1 / 258 | 9% | 0.20 | 20 / 230 |
eye | 0% | 0 | 0 / 0 | 9% | 0.24 | 7 / 80 |
heart | 9% | 13.80 | 75 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 1.49 | 9 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0033077 | Biological process | T cell differentiation in thymus |
GO_0033089 | Biological process | positive regulation of T cell differentiation in thymus |
GO_0050862 | Biological process | positive regulation of T cell receptor signaling pathway |
GO_0008104 | Biological process | protein localization |
GO_0036399 | Biological process | TCR signalosome assembly |
GO_0010387 | Biological process | COP9 signalosome assembly |
GO_0005737 | Cellular component | cytoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0036398 | Cellular component | TCR signalosome |
GO_0008180 | Cellular component | COP9 signalosome |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0043274 | Molecular function | phospholipase binding |
GO_0005102 | Molecular function | signaling receptor binding |
Gene name | TESPA1 |
Protein name | Thymocyte expressed, positive selection associated 1 Protein TESPA1 (Thymocyte-expressed positive selection-associated protein 1) |
Synonyms | HSPC257 KIAA0748 |
Description | FUNCTION: Required for the development and maturation of T-cells, its function being essential for the late stages of thymocyte development (By similarity). Plays a role in T-cell antigen receptor (TCR)-mediated activation of the ERK and NFAT signaling pathways, possibly by serving as a scaffolding protein that promotes the assembly of the LAT signalosome in thymocytes. May play a role in the regulation of inositol 1,4,5-trisphosphate receptor-mediated Ca(2+) release and mitochondrial Ca(2+) uptake via the mitochondria-associated endoplasmic reticulum membrane (MAM) compartment. . |
Accessions | ENST00000525978.5 E9PHY9 ENST00000533446.5 ENST00000526532.5 ENST00000524668.5 ENST00000532804.5 [A2RU30-2] E9PPW8 A2RU30 E9PIN8 ENST00000449076.6 [A2RU30-1] H0YEX3 ENST00000316577.12 [A2RU30-1] E9PM24 ENST00000528240.1 E9PIT9 H0YDP3 ENST00000531122.5 [A2RU30-2] ENST00000533607.1 ENST00000532757.5 E9PN46 ENST00000524923.5 ENST00000524622.5 [A2RU30-2] |